title: Hyaluronan synthases and hyaluronidases in nasal polyps.
abstract: Nasal polyps (NPs) are benign lesions of nasal and paranasal sinuses mucosa affecting 1-4 % of all adults. Nasal polyposis affects the quality of patient's life as it causes nasal obstruction, postnasal drainage, purulent nasal discharge, hyposmia or anosmia, chronic sinusitis, facial pain and snoring. Without treatment, the disease can alter the craniofacial skeleton in cases of extended growth of polyps. The development of NPs is caused by the hyperplasia of nasal or paranasal sinuses mucosa, and edema of extracellular matrix. This is usually the result of high concentration of high molecular mass hyaluronan (HA) which is either overproduced or accumulated from blood supply. The size of HA presents high diversity and, especially in pathologic conditions, chains of low molecular mass can be observed. In NPs, chains of about 200 kDa have been identified and considered to be responsible for the inflammation. The purpose of the present study was the investigation, in NPs and normal nasal mucosa (NM), of the expression of the wild-type and alternatively spliced forms of hyaluronidases, their immunolocalization, and the expression of HA synthases to examine the isoform(s) responsible for the increased amounts of HA in NPs. Hyaluronidases' presence was examined on mRNA (RT-PCR analysis) and protein (immunohistochemistry) levels. Hyaluronan synthases' presence was examined on mRNA levels. Hyaluronidases were localized in the cytoplasm of epithelial and inflammatory cells, as well as in the matrix. On mRNA level, it was found that hyal-1-wt was decreased in NPs compared to NM and hyal-1-v3, -v4 and -v5 were substantially increased. Moreover, HAS2 and HAS3 were the only hyaluronan synthases detected, the expression of which was almost similar in NPs and NM. Overall, the results of the present study support that hyaluronidases are the main enzymes responsible for the decreased size of hyaluronan observed in NPs; thus they behave as inflammatory agents. Therefore, they could be a potential target for the design of a more advanced treatment for nasal polyposis.
authors.affiliation: Department of Otorhinolaryngology-Head and Neck Surgery, University Hospital of Patras, University of Patras Medical School, 26500, Patras, Greece. dpanog.orl@gmail.com.
authors.forename: T
authors.initials: T
authors.lastname: Panogeorgou
authors.affiliation: Biochemistry, Biochemical Analysis and Matrix Pathobiology Research Group, Laboratory of Biochemistry, Department of Chemistry, University of Patras, 26500, Patras, Greece.
authors.forename: E
authors.initials: E
authors.lastname: Tserbini
authors.affiliation: Biochemistry, Biochemical Analysis and Matrix Pathobiology Research Group, Laboratory of Biochemistry, Department of Chemistry, University of Patras, 26500, Patras, Greece.
authors.forename: S
authors.initials: S
authors.lastname: Filou
authors.affiliation: Biochemistry, Biochemical Analysis and Matrix Pathobiology Research Group, Laboratory of Biochemistry, Department of Chemistry, University of Patras, 26500, Patras, Greece.
authors.forename: D H
authors.initials: DH
authors.lastname: Vynios
authors.affiliation: Department of Otorhinolaryngology-Head and Neck Surgery, University Hospital of Patras, University of Patras Medical School, 26500, Patras, Greece.
authors.forename: S S
authors.initials: SS
authors.lastname: Naxakis
authors.affiliation: Department of Otorhinolaryngology-Head and Neck Surgery, University Hospital of Patras, University of Patras Medical School, 26500, Patras, Greece.
authors.forename: T A
authors.initials: TA
authors.lastname: Papadas
authors.affiliation: Department of Otorhinolaryngology-Head and Neck Surgery, University Hospital of Patras, University of Patras Medical School, 26500, Patras, Greece.
authors.forename: P D
authors.initials: PD
authors.lastname: Goumas
authors.affiliation: Department of Otorhinolaryngology-Head and Neck Surgery, University Hospital of Patras, University of Patras Medical School, 26500, Patras, Greece.
authors.forename: N S
authors.initials: NS
authors.lastname: Mastronikolis
mesh_terms: D000328:Adult; D002908:Chronic Disease; D005260:Female; D005786:Gene Expression Regulation; D014453:Glucuronosyltransferase / Q000096:biosynthesis / Q000235:genetics*; D006801:Humans; D000076002:Hyaluronan Synthases; D006821:Hyaluronoglucosaminidase / Q000096:biosynthesis / Q000235:genetics*; D007150:Immunohistochemistry; D008297:Male; D009297:Nasal Mucosa / Q000378:metabolism / Q000473:pathology; D009298:Nasal Polyps / Q000201:enzymology / Q000235:genetics* / Q000473:pathology; D012333:RNA, Messenger / Q000235:genetics*; D060888:Real-Time Polymerase Chain Reaction
chemical_list: D012333:RNA, Messenger; D014453:Glucuronosyltransferase; D000076002:Hyaluronan Synthases; D006821:Hyaluronoglucosaminidase
keywords: HAS; Hyal; Hyaluronan; Inflammation; Nasal polyps; Rhinitis